Letters to the Editor

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

Guy's and St Thomas' NHS Foundation Trust, London
The University of Kansas Cancer Center, Kansas City
Fred Hutchinson Cancer Research Center, Seattle, WA
University of Oxford, Oxford
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
Hôpital Saint-Louis, Université Paris Cité, Paris
Mays Cancer Center at UT Health San Antonio, San Antonio
Somogy County Mór Kaposi General Hospital, Kaposvár
Universitätsklinikum Köln (AöR), Cologne
Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid
University of Oxford, Oxford
CTI Biopharma Inc, Seattle, WA
CTI Biopharma Inc, Seattle, WA
Icahn School of Medicine at Mount Sinai, New York
Vol. 108 No. 7 (2023): July, 2023 https://doi.org/10.3324/haematol.2022.282089